Form D · Pharmaceuticals
BIORELIX INC
New Haven, CT · CIK 0001373982
Offering snapshot reported Mar 13, 2012 · SEC filing
- Reported sold
- $2.56M Offering amount: $2.56M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2012 | Initial | $2,558,096 | No comparison | 8 | SEC filing |
| Sep 2, 2011 | Initial | $3,644,085 | No comparison | 8 | SEC filing |
| Dec 22, 2010 | Initial | $2,400,000 | No comparison | 7 | SEC filing |
| Jan 27, 2010 | Amendment | $5,535,199 | $3,745,694vs Jul 15, 2009 | 7 | SEC filing |
| Jul 15, 2009 | Initial | $1,789,505 | No comparison | 7 | SEC filing |
| Jun 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-174840
Offering of Promissory Notes and Warrants
Source: Form D, filed Mar 13, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Philipe Chambon | Director |
| Philippe Chambon | Director |
| Phillipe Chambon | Director |
| Brian R. Dixon, Ph.D | Director, Executive |
| Dov Goldstein | Director |
| Ronald Lennox | Director, Executive |
| Jonathan M. Lourie | Executive |
| Campbell Murray | Director |
| A. Donny Strosberg | Director |
| A. Donny Strosberg | Director |
| William Wiesler | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5 Science Park 401 Winchester Avenue
New Haven, CT, 06511
New Haven, CT, 06511